Airain Ltd’s Bristol-Myers Squibb BMY Stock Holding History

Airain Ltd’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$527K	Buy	+9,461	New	+$515K	0.02%	530
2016 Q4	–	Sell	-397,788	Closed	-$21.4M	–	667
2016 Q3	$21.4M	Buy	397,788 +364,430	+1,092%	+$23.4M	1.27%	3
2016 Q2	$2.45M	Buy	+33,358	New	+$2.36M	0.14%	195
2014 Q4	–	Sell	-70,675	Closed	-$3.62M	–	715
2014 Q3	$3.62M	Sell	70,675 -32,413	-31%	-$1.62M	0.25%	105
2014 Q2	$5M	Buy	103,088 +96,113	+1,378%	+$4.74M	0.41%	59
2014 Q1	$362K	Buy	+6,975	New	+$371K	0.06%	428

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Airain Ltd's BMY Position: Q2 2017 in Review

Airain Ltd opened a new position in Bristol-Myers Squibb (BMY) in Q2 2017: 9,461 shares worth $527K. The stake represents 0.02% of the portfolio and ranks #530 among its holdings. This is a return to the name: Airain Ltd previously reported a position in BMY as recently as Q3 2016.

Airain Ltd first reported a position in BMY in Q1 2014 and has held it in 6 quarters since. The position peaked at $21.4M in Q3 2016. 1,594 funds tracked by Wall St. Rank hold BMY as of Q2 2017.

Airain Ltd held 9,461 shares of Bristol-Myers Squibb worth $527K as of Q2 2017.
Bristol-Myers Squibb was a new Airain Ltd position in Q2 2017.
Bristol-Myers Squibb made up 0.02% of Airain Ltd's portfolio in Q2 2017, its #530 holding.
Airain Ltd first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 6 quarters since.
Airain Ltd's Bristol-Myers Squibb position peaked at $21.4M in Q3 2016.
1,594 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.